Abstract

A long-term observation of ophthalmology assessment in atypical CLN2 patients receiving ICV cerliponase alfa treatment

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call